Managing Toxicities from Chronic Myeloid Leukemia Treatment
2 Mga view
administrator
07/08/23
The panelists, Jorge Cortes, MD; Javier Pinilla-Ibarz, MD, PhD; Kevin Kelly, MD, PhD; David Snyder, MD, FACP; and Harry Erba, MD, PhD, comment on strategies to manage adverse events from tyrosine kinase inhibitor therapy used in the treatment of chronic myeloid leukemia.
Magpakita ng higit pa
Mga Komento sa Facebook
Walang nakitang komento